MYUNGMOON Pharm co.,Ltd (KRX:017180)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,788.00
+32.00 (1.82%)
Apr 29, 2026, 3:30 PM KST
9.09%
Market Cap 59.77B
Revenue (ttm) 195.25B
Net Income (ttm) 1.90B
Shares Out 33.43M
EPS (ttm) 57.00
PE Ratio 31.37
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 177,143
Average Volume 84,408
Open 1,753.00
Previous Close 1,756.00
Day's Range 1,743.00 - 1,793.00
52-Week Range 1,530.00 - 2,055.00
Beta 0.42
RSI 46.94
Earnings Date May 14, 2026

About MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics,... [Read more]

Sector Healthcare
Founded 1983
Employees 291
Stock Exchange Korea Stock Exchange
Ticker Symbol 017180
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.